{
  "weekly_top_story": {
    "headline": "FDA Approves First-of-Its-Kind Treatment for Rare Genetic Disease",
    "summary": "The FDA's approval of a novel gene therapy marks a significant advancement in treating a previously incurable genetic disorder, offering hope to affected patients and families.",
    "source": "Reuters",
    "importance": 5,
    "impact_to_me": 3,
    "category": "Pharma",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/fda-approves-first-of-its-kind-treatment-rare-genetic-disease-2024-10-27"
  },
  "stories": [
    {
      "headline": "New Study Highlights Potential Link Between Air Pollution and Asthma Exacerbations",
      "summary": "Research published in the Lancet reveals a strong correlation between increased air pollution levels and a rise in asthma-related hospital admissions, underscoring the need for stricter environmental regulations.",
      "source": "The Lancet",
      "importance": 4,
      "impact_to_me": 4,
      "category": "Research",
      "url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02467-2/fulltext"
    },
    {
      "headline": "CMS Proposes Changes to Medicare Advantage Plans for 2025",
      "summary": "The Centers for Medicare & Medicaid Services (CMS) announced proposed changes to Medicare Advantage plans for 2025, impacting provider reimbursements and patient access to certain services.",
      "source": "Healthcare Dive",
      "importance": 3,
      "impact_to_me": 4,
      "category": "Policy",
      "url": "https://www.healthcaredive.com/news/cms-proposes-changes-to-medicare-advantage-plans-for-2025/690707/"
    }
  ]
}